This trial was designed to study the effectiveness of a drug called Nam for preventing acute kidney injury in patients undergoing heart surgery.
1 Primary · 2 Secondary · Reporting Duration: At 6, 12, 24, and 48 hours post operatively
Experimental Treatment
Non-Treatment Group
304 Total Participants · 2 Treatment Groups
Primary Treatment: Niacinamide · Has Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: